See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no specified weight limit for the dosage of Cosentyx (secukinumab) [1]. The dosage is typically determined by the patient's health condition, such as plaque psoriasis, psoriatic arthritis, or ankylosing spondylitis, and the response to treatment [1].

The prescribing information for Cosentyx, provided by the FDA, does not mention a weight limit for the drug [2]. However, it does provide guidelines for dosage based on the patient's weight for the initial dose, but this is not a strict limit [2].

It is important to note that the dosage of any medication should be determined by a healthcare professional, taking into account various factors including the patient's weight, age, overall health status, and the specific condition being treated [1][2].

Sources:
[1] DrugPatentWatch.com, "Cosentyx (secukinumab) Dosage", https://drugpatentwatch.com/drugs/cosentyx/secukinumab/dosage
[2] Novartis Pharmaceuticals Corporation, "Full Prescribing Information", Cosentyx (secukinumab), https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx.pdf